A question of ownership.

Australian Doctor,  April, 2007  

• E-mail
• Print
• Link

By Bianca Nogrady

Questions over the ownership of the H5N1 influenza strain raise wider issues about medical research, individual rights and company profits.

WHEN CSL proudly announced in January that it was applying to register its pandemic influenza vaccine, the company could not have foreseen that its supporting dossier would spark a global storm with far-reaching implications for vaccine research.

Within 24 hours the Indonesian Government made headlines by declaring it was seeking intellectual property rights over the Indonesian strain of the H5N1 influenza virus, and ...

Read the rest of this article with a Free Trial at HighBeam Research.